Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FRES - Fresh2 Group Ltd

1.13
-0.240   -21.239%

Share volume: 0
Last Updated: Mon 23 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.12%

PREVIOUS CLOSE
CHG
CHG%
$1.37
-0.24
-17.52%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-50.00%
6 Months
-53.30%
1 Year
141.13%
2 Year
-90.87%
Key data
Stock price
$1.13
P/E Ratio 
0.00
DAY RANGE
$1.13 - $1.37
EPS 
N/A
52 WEEK RANGE
$0.30 - $3.70
52 WEEK CHANGE
$141.13
MARKET CAP 
17.519 M
YIELD 
N/A
SHARES OUTSTANDING 
8.804 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Haohan Xu
Region: US
Website: fresh2.co
Employees: 75
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Recent news